ATE3058T1 - Herpes-virus-impfstoff und seine herstellung. - Google Patents

Herpes-virus-impfstoff und seine herstellung.

Info

Publication number
ATE3058T1
ATE3058T1 AT79400495T AT79400495T ATE3058T1 AT E3058 T1 ATE3058 T1 AT E3058T1 AT 79400495 T AT79400495 T AT 79400495T AT 79400495 T AT79400495 T AT 79400495T AT E3058 T1 ATE3058 T1 AT E3058T1
Authority
AT
Austria
Prior art keywords
manufacture
herpes virus
virus vaccine
vaccine
virus
Prior art date
Application number
AT79400495T
Other languages
English (en)
Inventor
William Joseph Mcaleer
Henry Zvi Markus
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE3058T1 publication Critical patent/ATE3058T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT79400495T 1978-07-21 1979-07-12 Herpes-virus-impfstoff und seine herstellung. ATE3058T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92706978A 1978-07-21 1978-07-21
EP19790400495 EP0008255B1 (de) 1978-07-21 1979-07-12 Herpes-Virus-Impfstoff und seine Herstellung

Publications (1)

Publication Number Publication Date
ATE3058T1 true ATE3058T1 (de) 1983-04-15

Family

ID=25454121

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79400495T ATE3058T1 (de) 1978-07-21 1979-07-12 Herpes-virus-impfstoff und seine herstellung.

Country Status (12)

Country Link
EP (1) EP0008255B1 (de)
JP (1) JPS5519271A (de)
AT (1) ATE3058T1 (de)
AU (1) AU532186B2 (de)
DE (1) DE2965191D1 (de)
DK (1) DK306379A (de)
ES (1) ES8107300A1 (de)
HU (1) HU182530B (de)
IE (1) IE48379B1 (de)
PL (1) PL217216A1 (de)
PT (1) PT69953A (de)
RO (1) RO76563A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
FR2804026B1 (fr) 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
CA2859916C (en) 2012-01-09 2021-02-09 Sanofi Pasteur Biologics, Llc Purification of herpes virus
CA2873775C (en) 2012-05-21 2021-04-20 Sanofi Pasteur Limited Herpesvirus compositions and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof

Also Published As

Publication number Publication date
HU182530B (en) 1984-01-30
IE48379B1 (en) 1984-12-26
AU4882079A (en) 1980-01-24
DK306379A (da) 1980-01-22
PT69953A (en) 1979-08-01
JPS5519271A (en) 1980-02-09
PL217216A1 (de) 1980-12-15
ES482549A0 (es) 1980-12-16
EP0008255A1 (de) 1980-02-20
RO76563A2 (ro) 1981-04-30
EP0008255B1 (de) 1983-04-13
AU532186B2 (en) 1983-09-22
JPS6332768B2 (de) 1988-07-01
DE2965191D1 (en) 1983-05-19
ES8107300A1 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
ATE127694T1 (de) Lebende impfstoffe.
FR2522967B1 (fr) Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
ATE43500T1 (de) Herstellung von antikoerpern.
ATE3058T1 (de) Herpes-virus-impfstoff und seine herstellung.
NO870123D0 (no) Mastittvaksine.
DE3784397D1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
MX9102757A (es) Vacuna de virus de enfermedad de marek sin celulas.
MX9602256A (es) Vacuna contra la enfermedad de marek.
ATE83929T1 (de) Schweinenierenzellkultur und ihre verwendung fuer die herstellung von vakzinen.
ES2089371T3 (es) Vacuna contra las enfermedades respiratorias para gatos.
ATE18007T1 (de) Hepatitisimpfstoff.
EP0496787A4 (en) Novel infectious bursal disease virus
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
JPS5589232A (en) Vaccines against reo virus disease and their manufacture
DK569985D0 (da) Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
ATE159758T1 (de) Azelluläre impfstoffe
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
GB990733A (en) Viral preparations
RU93031951A (ru) Комбинированная вакцина против ньюкаслской болезни и инфекционного ларинготрахеита птиц

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee